Kane Biotech Inc News - KNE | Aktien TSX Venture Börse

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

WINNIPEG, Manitoba, March 13, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) ("Kane...

Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, March 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane...

Kane Biotech Announces Second and Final Closing of Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Feb...

Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”...

Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Jan...

Kane Biotech Announces $3,000,000 Private Placement Offering

WINNIPEG, Manitoba, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the...

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane...

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the...

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane...

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the...

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the...

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the...

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane...

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane...

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane...

Rendering Error

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kane Biotech Inc (KNE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

KNE Nachrichten

Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel

Kane Biotech Announces Second and Final Closing of Private Placement Offering

Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering

Kane Biotech Announces $3,000,000 Private Placement Offering

Kane Biotech Announces Third Quarter 2024 Financial Results

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

Kane Biotech Announces Agreement to Acquire FB Dermatology

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

KNE Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kane Biotech Inc (KNE) News

Kane Biotech Inc (KNE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

KNE Nachrichten

Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel

Kane Biotech Announces Second and Final Closing of Private Placement Offering

Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering

Kane Biotech Announces $3,000,000 Private Placement Offering

Kane Biotech Announces Third Quarter 2024 Financial Results

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

Kane Biotech Announces Agreement to Acquire FB Dermatology

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

KNE Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen